Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Multicentre Prospective Cohort Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
A multicenter prospective cohort study in India evaluating the gastric precancerous epithelial pathway using high-definition endoscopy and h…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]
Phase 1 clinical trial update for AVA6103 in patients with locally advanced or metastatic selected solid tumors; the study is currently recr…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating SHR-1701 with or without apatinib plus chemotherapy as neoadjuvant therapy for gastric adenocarc…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels [Phase 2]
Phase 2 Yale-sponsored trial evaluating adding sequential cytoreductive intervention to standard-of-care therapy for metastatic foregut aden…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer [NA]
A clinical trial update describes assessing adherence to remotely monitored physical activity via a smartwatch and its potential to reduce f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin and liposomal irinotecan with trastuzumab for HER2-positive disease in advanced esophageal a…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma
This clinical trial update describes a real-world study of zolbetuximab in patients with HER-2 negative, Claudin-18.2–positive metastatic ga…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating perioperative chemotherapy with low-dose radiotherapy and tislelizumab for locally advanced gastric or gastroesopha…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction [Phase 1]
A Phase 1 study of IM96 CAR-T Cell Therapy for advanced gastric adenocarcinoma and esophagogastric junction adenocarcinoma. The trial status…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]
Phase 1 study update for NRM-823 in locally advanced or metastatic refractory solid tumors, currently recruiting. The trial lists head and n…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma [Phase 3]
A Phase III clinical trial is evaluating Cadonilimab in combination with the SOX chemotherapy regimen as perioperative treatment for patient…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma
The study, sponsored by Nanfang Hospital and Southern Medical University, is evaluating an artificial intelligence model to aid Claudin18.2 …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study Collecting Health Information to Understand and Prevent Gastric Cancer
This recruiting clinical trial, sponsored by Memorial Sloan Kettering Cancer Center, seeks to collect health information to understand and p…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu [EARLY_Phase 1]
Early-phase trial update on ProofPrincip intra-tumoral T cells with a single-dose checkpoint inhibitor for gastroesophageal adenocarcinoma w…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with trastuzumab and chemotherapy for patients with esophagogastric cancer.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Registry Platform Gastric/Esophageal Cancer (SAPHIR)
This Clinical Trial Update reports an ongoing registry platform trial SAPHIR addressing gastric and esophageal cancers, currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of KK2269 in Adult Participants With Solid Tumors [Phase 1]
Phase 1 study update for KK2269 in adults with solid tumors; the trial is currently recruiting. Indications include gastric adenocarcinoma, …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma [Phase 3]
Clinical trial update for ASKB589 in combination with CAPOX and a PD-1 inhibitor for advanced or metastatic gastric/gastroesophageal junctio…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer [Phase 1, Phase 2]
Bolt Biotherapeutics is conducting a first-in-human Phase 1/2 study of BDC-4182 as a single-agent therapy in metastatic gastric adenocarcino…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer [Phase 2, Phase 3]
A perioperative trial investigating the combination of SOX chemotherapy with Apatinib and Camrelizumab for gastric and gastroesophageal junc…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) [Phase 2]
A Phase 2 trial (VIKTORY-2) is evaluating the combination of savolitinib and durvalumab in MET-amplified advanced gastric cancer and is curr…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma [Phase 2]
A Phase 2 neoadjuvant trial evaluating intra-tumoral RP2 in combination with the FLOT regimen for gastric and esophageal adenocarcinoma is l…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating Fruquintinib in combination with Trastuzumab and XELOX as first-line thera…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer [Phase 2]
Phase II trial (RAINSPOT) evaluating zolbetuximab combined with paclitaxel and ramucirumab in CLDN18.2-positive gastric and gastroesophageal…